Vanson Contracts For LipoSan Study

Vanson Contracts For LipoSan Study

REDMOND,Wash.--Vanson Inc. has contracted with Graham, Wash.-based Genesis Center for Integrative Medicine to clinically study its LipoSan Ultrachitosan. This eight-week, double-blind study will involve 60 patients taking either LipoSan Ultra or placebo. This will be the first double-blind trial involving LipoSan Ultra, with results expected by early 2001. The study will focus on the effect of Vanson's patented chitosan ingredient as a weight-loss management tool. For more information, visit www.wilkeresources.com or Booth #1539-1541 at SupplySide West.